Prerna Mewawalla MD
Hematologic Oncology
Myeloma & Transplant Physician | Associate Professor, Drexel | Medical Director, Apheresis, AHN | Chair, Women Physicians ERG | Board Member, ACMS | Dist 13 Representative, PAMED House of Delegates | National Speaker
Join to View Full Profile
4815 Liberty AvePittsburgh, PA 15224
Phone+1 412-578-4893
Dr. Mewawalla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Board-certified hematologist specializing in multiple myeloma, AL amyloidosis, and stem cell transplantation. Medical Director of Apheresis and Cancer Institute Executive Committee member at AHN. Associate Professor at Drexel. Serves on the ACMS Board and PAMED House of Delegates. Advocate for physician wellness, mentorship, gender equity, and advancing care in plasma cell disorders.
Education & Training
Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2012 - 2015
University of ConnecticutResidency, Internal Medicine, 2009 - 2012
Seth G.S. Medical CollegeClass of 2007
Certifications & Licensure
PA State Medical License 2012 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma.Carmel Awadallah, Shebli Atrash, Barry Paul, Abdullah Mohammad Khan, Hira Shaikh
Expert Review of Hematology. 2026-05-30 - High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.Carmel Awadallah, Anas Zayad, Shebli Atrash, Anita Mazloom, Omar Alkharabsheh
Current Oncology. 2026-04-27 - Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients.Raeef Rahman, Anas Zayad, Carmel Awadallah, Beining Wang, Jianzheng Wu
Current Oncology. 2026-04-26
Press Mentions
Al-Ola a Abdallah: Dr. Mewawalla’s Presentation on Advances in CAR-T Therapies for Myeloma at ICET CongressSeptember 29th, 2025
Smart Apps for Smart DocsAugust 31st, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
